Clinical Trials Sponsored by Abbott (Peru)

Total 2676 results

Abbott

Completed

A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis (PRIDE)

Psoriasis

Canada
Abbott

Completed

Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart Disease

Severe Respiratory Syncytial Virus Infection

Austria, Belgium, France, Germany, Italy, Norway, Poland, Slovenia, Spain, United Kingdom
Abbott

Completed

Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain

Moderate to Severe Chronic, Non-malignant Pain

United States
Abbott

Completed

A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR)and Placebo in Subjects With Osteoarthritis

Pain
Abbott

Completed

Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis

Kidney Disease

United States
Abbott

Terminated

A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer | Lung Cancer

United States, Canada, Ireland, United Kingdom
Abbott

Completed

Phase 1 BA Study, Single Center With Healthy Volunteers

Healthy

United States
Abbott

Completed

Pharmacokinetic Study of ABT-126 in Healthy Volunteers

Healthy Volunteers

United States
Abbott

Completed

A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects

Healthy Volunteers

United States
Abbott

Completed

Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers

Healthy

United States
Abbott

Completed

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

Psoriasis

United States, Canada
Abbott

Completed

A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults

Hepatitis C

United States
Abbott

Completed

Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

Healthy

United States
Abbott

Completed

Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

HCV Infection

United States
Abbott

Completed

A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333

HCV Infection

United States
Abbott

Completed

Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

HCV Infection

United States
Abbott

Completed

A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients (SCOUT)

Obesity

United States
Abbott

Completed

A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease

Secondary Hyperparathyroidism | Chronic Kidney Disease, Stage 5

United States
Abbott

Completed

Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia (ASA EFFECTS)

Dyslipidemia

United States
Abbott

Completed

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

Leiomyoma
Abbott

Completed

A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors

HIV Infections

United States
Abbott

Completed

A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

HIV Infections

United States, Canada, Switzerland, France, Germany, United Kingdom, Brazil, Austria, Australia, Denmark, Poland, South Africa, Spain, Puerto Rico
Abbott

Completed

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

HIV Infections

United States
Abbott

Terminated

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

HIV Infection

United States
Abbott

Completed

Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

Prostatic Neoplasms

United States
Abbott

Completed

Safety of Treatment of Uterine Fibroids With Asoprisnil

Metrorrhagia | Leiomyoma | Uterine Fibroids | Menorrhagia | Fibroid Uterus
Abbott

Completed

A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis

Endometriosis
Abbott

Completed

Study of Asoprisnil in the Treatment of Uterine Fibroids.

Metrorrhagia | Leiomyoma | Uterine Fibroids | Menorrhagia | Fibroid Uterus
Abbott

Approved for marketing

Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis (ReAct)

Rheumatoid Arthritis
Abbott

Completed

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

HIV Infections

France, Spain, United States, Canada, Poland, Argentina, Brazil, Germany, Italy, Puerto Rico, United Kingdom
Abbott

Completed

Paricalcitol Injection Phase II Trial

Chronic Kidney Disease

Japan
Abbott

Completed

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

End Stage Renal Disease

Poland, United States
Abbott

Completed

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

Arthritis | Psoriatic
Abbott

Completed

A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

Healthy

United States
Abbott

Completed

A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications

Healthy

United States
Abbott

Completed

Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis

Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB).

United States, Canada, Puerto Rico
Abbott

Completed

A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media

Acute Otitis Media

United States
Abbott

Completed

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
Abbott

Completed

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Breast Cancer

United States
Abbott

Completed

Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine

Migraine

United States
Abbott

Completed

A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

Obesity | Binge Eating Disorder
Abbott

Completed

A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.

Migraines

United States
Abbott

Completed

A Study for Treatment of Partial Seizures in Children

Partial Seizures

United States
Abbott

Terminated

A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

Alzheimer's Disease

United States
Abbott

Completed

Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure

Prostatic Neoplasms

United States, Canada
Abbott

Completed

Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Renal Insufficiency, Chronic

United States, Poland
Abbott

Completed

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Crohn's Disease

United States
Abbott

Completed

Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium

Chronic Kidney Disease | Secondary Hyperparathyroidism

United States
Abbott

Completed

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)

Renal Insufficiency, Chronic

United States, Poland
Abbott

Completed

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

Hypocalcemia

United States

3

Subscribe